z-logo
Premium
Management of a pemphigus with IgA and IgG antibodies and coexistent lung cancer
Author(s) -
Cetkovská Petra,
Komorousová Michaela,
Lomicová Iva
Publication year - 2014
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12126
Subject(s) - pemphigus , paraneoplastic pemphigus , medicine , dapsone , immunoglobulin a , antibody , immunology , autoantibody , lung cancer , immunoglobulin g , pemphigus foliaceus , pathology
Immunoglobulin A ( I g A ) pemphigus is a clinically distinct variant of pemphigus characterized by intercellular I g A deposition in the epidermis. Recently, an I g A /Immunoglobulin G ( I g G ) subset of pemphigus with I g A and I g G anti‐keratinocyte cell surface antibodies has been described. Both I g A and I g A / I g G pemphigus have been associated with internal malignancies. Above all, monoclonal I g A gammopathy in patients with I g A pemphigus has been reported, and lung cancers in association with I g A / I g G pemphigus have been described. I g A pemphigus can be successfully treated with dapsone, whereas therapeutic management of I g G / I g A pemphigus is not well established yet. We report a rare case of a patient, who developed atypical pemphigus with both I g A and I g G autoantibodies and an underlying lung cancer, successfully treated with corticosteroids and dapsone.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom